Showing results (21-30 of 177) with videos related to
Sort By:
Pageof 18
Cancer|December 1, 1978
Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanomaS E Krown, E Y Hilal, C M Pinsky, et al.Cancer Treatment Reports|January 1, 1985
Intravesical administration of bacillus Calmette-Guérin in patients with recurrent superficial carcinoma of the urinary bladder: report of a prospective, randomized trialC M Pinsky, F J Camacho, D Kerr, et al.Cancer|July 15, 1981
Surgical adjuvant therapy of malignant melanoma with corynebacterium parvumE Y Hilal, C M Pinsky, Y Hirshaut, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancerR A Badalament, H W Herr, G Y Wong, et al.The Journal of Urology|May 1, 1985
Monitoring intravesical bacillus Calmette-Guerin treatment of bladder carcinoma with flow cytometryL Staiano-Coico, J Huffman, R Wolf, et al.Cancer|March 15, 1980
Immunotherapy of colon cancer: prospects for developing immunogenic vaccines based on autologous serological typingH F Oettgen, L J OldCancer Research|October 1, 1985
Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladderJ L Huffman, Y Fradet, C Cordon-Cardo, et al.The Journal of Experimental Medicine|October 1, 1976
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigensH Shiku, T Takahashi, H F OettgenInternational Journal of Cancer|October 15, 1982
Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cellsP O Livingston, T Watanabe, H Shiku, et al.Pageof 18